PDCD1 and neoplasm: The tumor growth and tumor burden in 4T1 cell‐implanted mice treated with both 6J1 and anti‐PD‐1 antibody were significantly weaker when compared with 4T1 cell‐implanted mice treated with 6J1 or anti‐PD‐1 antibody alone (Figure 7B–D).